Select a medication above to begin.
fluvoxamine
generic
Black Box Warnings .
Suicidality
incr. suicidality risk in children, adolescents, and young adults w/ major depressive or other psychiatric disorders; weigh risk vs. benefit; in short-term studies of antidepressants vs. placebo, suicidality risk not incr. in pts >24 yo, and risk decr. in pts 65 yo and older; depression and certain other psychiatric disorders themselves assoc. w/ incr. suicide risk; observe all pts for clinical worsening, suicidality, or unusual behavior changes; advise families and caregivers of need for close observation and communication w/ prescriber; not approved in peds pts except for obsessive compulsive disorder
Adult Dosing .
Dosage forms: ER CAP: 100 mg, 150 mg; TAB: 25 mg, 50 mg, 100 mg
obsessive-compulsive disorder
- [immediate-release form]
- Dose: 50-150 mg PO bid; Start: 50 mg PO qhs, may incr. by 50 mg/day q4-7 days; Max: 300 mg/day; Info: titrate slowly in elderly pts; taper dose gradually to D/C
- [extended-release form]
- Dose: 100-300 mg ER PO qhs; Start: 100 mg ER PO qhs, may incr. by 50 mg/day qwk; Max: 300 mg/day ER; Info: titrate slowly in elderly pts; taper dose gradually to D/C
social anxiety disorder (off-label)
- [100-300 mg ER PO qhs]
- Start: 100 mg ER PO qhs, may incr. by 50 mg/day qwk; Max: 300 mg/day ER; Info: titrate slowly in elderly pts; taper dose gradually to D/C
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [immediate-release form]
- hepatic impairment: decr. usual start dose, amount not defined; Info: titrate slowly
- [extended-release form]
- hepatic impairment: not defined; Info: titrate slowly
Peds Dosing .
- Dosage forms: TAB: 25 mg, 50 mg, 100 mg
obsessive-compulsive disorder
- [8-17 yo]
- Dose: 50-200 mg/day PO divided qd-bid; Start: 25 mg PO qhs, may incr. by 25 mg/day q4-7 days; Max: 200 mg/day in pts up to 11 yo, 300 mg/day in pts >11 yo; Info: consider lower doses in female children; divide doses >50 mg/day; taper dose gradually to D/C
- [>17 yo]
- Dose: 50-150 mg PO bid; Start: 50 mg PO qhs, may incr. by 50 mg/day q4-7 days; Max: 300 mg/day; Info: taper dose gradually to D/C
generalized anxiety disorder (off-label)
- [8-17 yo]
- Dose: 50-200 mg PO qd-bid; Start: 25 mg PO qhs, incr. by 25 mg/day q4-7 days; Max: 200 mg/day in pts up to 11 yo, 300 mg/day in pts >11 yo; Info: consider lower doses in female children; divide doses >50 mg/day; taper dose gradually to D/C
post-traumatic stress disorder (off-label)
- [8-17 yo]
- Dose: 50 mg PO qd-bid; Start: 25 mg PO qhs, incr. by 25 mg/day q4-7 days; Max: 200 mg/day in pts up to 11 yo, 300 mg/day in pts >11 yo; Info: consider lower doses in female children; divide doses >50 mg/day; taper dose gradually to D/C
renal dosing
- [not defined]
- renal impairment: consider adult renal dosing for guidance
- HD/PD: consider adult renal dosing for guidance
hepatic dosing
- [see below]
- hepatic impairment: decr. usual start dose, amount not defined; Info: titrate slowly